Brief: Median Technologies Says U.S. FDA Filing For Eyonis LCS On Track For May 2025
31/03/2025 17:46
March 31 (Reuters) - Median Technologies SA ALMDT.PA: MEDIAN TECHNOLOGIES SA: U.S. FDA FILING FOR EYONIS LCS ON TRACK FOR MAY 2025 Source text: ID:nBw2dtzh1a Further company coverage: ALMDT.PA (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Median Technologies SA
See all newsBrief: Median Technologies Forms Strategic Review Committee To Consider iCRO Separation, US Listing
France's Median Technologies H1 order backlog rises on demand from biopharmaceutical clients
Brief: Median Technologies H1 Revenue EUR 11.8 Million
Brief: Median Launches Eur 40 Mln Capital Raise To Fund Eyonis Rollout, Extend Runway To H1 2028
Brief: Median Technologies Reports FY Revenue EUR 23.5 Million